Navigation Links
Rice University expert calls for coordination in nanotechnology research
Date:10/31/2007

Nanotechnology holds great promise for the future of cancer therapy and water treatment, but concerns about the safety of nanoproducts may limit these important technological developments, Vicki Colvin said today in comments to the U.S. House Committee on Science and Technology.

Colvin, director of Rice University's Center for Biological and Environmental Nanotechnology (CBEN) and executive director of the International Council on Nanotechnology (ICON), was an expert witness at the hearing "Research on Environmental and Safety Impacts of Nanotechnology." The hearing relates to the current direction of the National Nanotechnology Initiative (NNI).

Colvin told the committee she was providing her individual opinions, which have been informed by ICON's work with diverse international stakeholders on nanotechnology research needs in the areas of environment, health and safety (EHS). ICON also hosts a free, searchable database of EHS research papers.

"There is an urgency to nano-EHS research that affects the entire NNI investment," she said. "Innovation in nanotechnology is being threatened by the uncertainty about its risks. We need this innovation more than ever right now."

She called on the National Nanotechnology Initiative to release a detailed strategy for nano-EHS research no later than fall 2008.

"Going from a climate of uncertainty to one of confidence in managing nanotechnology risk is a massive undertaking that will take years to fully develop," Colvin said. "It will also take careful planning and coordination among agencies in this government and abroad. The ultimate plan would be most effectively organized by two, maybe three, overarching outcomes that stakeholders agree will give us more confidence in managing risks."

Colvin emphasized the importance of unifying "researchers' languages, methods and materials," which she referred to as "research harmonization" tools.

"If you fund five teams to help understand nanotube toxicity and they get five different answers, you are actually worse off because your research creates uncertainty rather than combat it," she said.

Colvin said there is a real need for government intervention.

"If left to ourselves, we might harmonize as a community in five to 10 years -- too long to wait for nanotechnology's innovation. The good news is that the U.S. government can, if it is thoughtful about the mechanisms, help researchers fix this problem quickly and for relatively low cost."


'/>"/>

Contact: David Ruth
druth@rice.edu
713-348-6327
Rice University
Source:Eurekalert

Related biology news :

1. University of Manchester makes made-to-measure skin and bones a reality using inkjet printers
2. New protein discovered by Hebrew University researchers
3. Next Generation Body Scanner Launched By The University Of Manchester
4. Roundup®highly lethal to amphibians, finds University of Pittsburgh researcher
5. Green catalyst destroys pesticides and munitions toxins, finds Carnegie Mellon University
6. University of Nevada, Reno research team discovers hormone that causes malaria mosquito to urinate
7. Carnegie Mellon University research reveals how cells process large genes
8. University of Delaware researchers develop cancer nanobomb
9. University of Arizona plant scientists to unravel maize genome
10. Team led by Carnegie Mellon University scientist finds first evidence of a living memory trace
11. University of Utah to help build bionic arm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... SAN RAFAEL, Calif., Feb. 23, 2017 ... of U.S. dollars, except per share data, unaudited)Three Months ... ChangeTotal BioMarin Revenue $ ...     22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
(Date:2/23/2017)...  Imanis Life Sciences announced today the launch ... viruses for virotherapy research. These viruses are licensed ... vaccinia virus-based technology platform for research use. ... partnership with Genelux to offer researchers, for the ... in research," said Dr. Kah Whye Peng ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... during the 12th annual Inventors Recognition Reception at Purdue Research Park ... a faculty member in recognition of outstanding contributions to, and success with, commercializing ...
Breaking Biology Technology: